Integrative analysis of the inverse expression patterns in pancreas development and cancer progression
- PMID: 31528097
- PMCID: PMC6718033
- DOI: 10.3748/wjg.v25.i32.4727
Integrative analysis of the inverse expression patterns in pancreas development and cancer progression
Abstract
Background: As the malignant tumor, pancreatic cancer with a meager 5-years survival rate has been widely concerning. However, the molecular mechanisms that result in malignant transformation of pancreatic cells remain elusive.
Aim: To investigate the gene expression profiles in normal or malignant transformed pancreas development.
Methods: MaSigPro and ANOVA were performed on two pancreas development datasets downloaded from the Gene Expression Omnibus database. Six pancreatic cancer datasets collected from TCGA database were used to establish differentially expressed genes related to pancreas development and pancreatic cancer. Moreover, gene clusters with highly similar interpretation patterns between pancreas development and pancreatic cancer progression were established by self-organizing map and singular value decomposition. Additionally, the hypergeometric test was performed to compare the corresponding interpretation patterns. Abnormal regions of metabolic pathway were analyzed using the Sub-pathway-GM method.
Results: This study established the continuously upregulated and downregulated genes at different stages in pancreas development and progression of pancreatic cancer. Through analysis of the differentially expressed genes, we established the inverse and consistent direction development-cancer pattern associations. Based on the application of the Subpathway-GM analysis, we established 17 significant metabolic sub-pathways that were closely associated with pancreatic cancer. Of note, the most significant metabolites sub-pathway was related to glycerophospholipid metabolism.
Conclusion: The inverse and consistent direction development-cancer pattern associations were established. There was a significant correlation in the inverse patterns, but not consistent direction patterns.
Keywords: Inverse pattern; Metabolites subpathway; Pancreas development; Pancreatic cancer.
Conflict of interest statement
Conflict-of-interest statement: The authors declare no conflict of interest.
Figures





Similar articles
-
Genes and proteins differentially expressed during in vitro malignant transformation of bovine pancreatic duct cells.Neoplasia. 2007 Feb;9(2):136-46. doi: 10.1593/neo.06754. Neoplasia. 2007. PMID: 17356710 Free PMC article.
-
Expression of HOXB2, a retinoic acid signaling target in pancreatic cancer and pancreatic intraepithelial neoplasia.Clin Cancer Res. 2005 May 1;11(9):3587-96. doi: 10.1158/1078-0432.CCR-04-1813. Clin Cancer Res. 2005. PMID: 15867264
-
Gene expression in pancreatic adenocarcinoma.Ann N Y Acad Sci. 1999 Jun 30;880:1-4. doi: 10.1111/j.1749-6632.1999.tb09504.x. Ann N Y Acad Sci. 1999. PMID: 10415845 Review.
-
Integrative analysis of lung development-cancer expression associations reveals the roles of signatures with inverse expression patterns.Mol Biosyst. 2015 May;11(5):1271-84. doi: 10.1039/c5mb00061k. Mol Biosyst. 2015. PMID: 25720795
-
Transition to pancreatic cancer in response to carcinogen.Langenbecks Arch Surg. 2008 Jul;393(4):557-60. doi: 10.1007/s00423-007-0274-2. Epub 2008 Jan 12. Langenbecks Arch Surg. 2008. PMID: 18189145 Review.
Cited by
-
Identification of hub genes correlated with the pathogenesis and prognosis in Pancreatic adenocarcinoma on bioinformatics methods.Transl Cancer Res. 2020 Aug;9(8):4550-4562. doi: 10.21037/tcr-19-2873. Transl Cancer Res. 2020. PMID: 35117820 Free PMC article.
-
Metabolomic biomarkers for the diagnosis and post-transplant outcomes of AFP negative hepatocellular carcinoma.Front Oncol. 2023 Feb 9;13:1072775. doi: 10.3389/fonc.2023.1072775. eCollection 2023. Front Oncol. 2023. PMID: 36845695 Free PMC article.
-
Cluefish: mining the dark matter of transcriptional data series with over-representation analysis enhanced by aggregated biological prior knowledge.NAR Genom Bioinform. 2025 Jul 30;7(3):lqaf103. doi: 10.1093/nargab/lqaf103. eCollection 2025 Sep. NAR Genom Bioinform. 2025. PMID: 40740691 Free PMC article.
References
-
- Cascinu S, Falconi M, Valentini V, Jelic S ESMO Guidelines Working Group. Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21:v55–v58. - PubMed
-
- Hidalgo M. Pancreatic cancer. N Engl J Med. 2010;362:1605–1617. - PubMed
-
- Bond-Smith G, Banga N, Hammond TM, Imber CJ. Pancreatic adenocarcinoma. BMJ. 2012;344:e2476. - PubMed
-
- Jennings RE, Berry AA, Strutt JP, Gerrard DT, Hanley NA. Human pancreas development. Development. 2015;142:3126–3137. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials